Peptides and monoclonal antibodies

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 14, 514 15, 530327, 530328, 5303873, 5303877, 5303891, 5303897, 5303892, 5303911, 4241331, 4241381, 4241361, 4241391, 4241411, 4241451, 4241551, 4241581, 4241811, A61K 39395

Patent

active

060249552

ABSTRACT:
A peptide corresponding to a portion of human vascular permeability factor (VPF) and a VPF monoclonal antibody recognizing the peptide are provided. The peptide of the invention is useful as an antigen for preparing a monoclonal antibody against VPF and as a reagent for biochemical analysis. The monoclonal antibody of the invention reactive with the above peptide is useful not only as a reagent for biochemical analysis but also as a diagnostic agent or therapeutic agent for various diseases such as cancer.

REFERENCES:
patent: 5569812 (1996-10-01), Monosov et al.
Osband et al, Immunology Today, vol. 11 p. 193, 1990.
Gura, Science vol. 278 p. 1041, Nov. 1997.
Dore, J.F. et al., 1987, "Metastases of human tumors in experimental animals," Anticancer Res. 7:997-1003.
Schackert, G. et al., 1989, "Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice", Int. J. Cancer 44:892-897.
Marincola, F.M. et al., 1989, "The nude mouse as a mode for the study of human pancreatic cancer," J. Surg. Res. 47:520-529.
Iwasaki, T. et al., 1997, "NG-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model", Jpn. J. Cancer Res. 88:861-866.
Rose, D.P. et al., 1995, "Influence of diets containing ecsapenic acid on growth and metastasis of breast cancer cells in nude mice", J. Natl. Cancer Inst. 87:587-592.
Marks et al., 1995, "A novel anti-seminoma monoclonal antibody (M2A) labeled with technetium-99m: Potential application for radioimmunoscintography", Br. J. Urol. 75:225-229.
Dooley, T.P. et al., 1993, "Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells", Lab Anim. Sci. 43:48-57.
Tibbetts, L.M. et al., 1993, "Liver metastases with 10 human colon carcinoma cell line in nude mice and association with carcinoembryonic antigen production," Cancer 71:315-21.
An, Z et al., 1996, "Interferon gamma is highly effective against orthotopically-implanted human pleural adenocarcinoma in nude mice", Anticancer Res. 26:2545-2551.
Bleumenthal, R.D. et al., 1996, "Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colon," Cancer Res. 56:3508-3515.
Velders, M.P. et al., 1995, "Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model," Cancer Res. 55:4398-4403.
Zhu, Z. et al., 1994, "Tumor localization and therapeutic potential of an antitumor-anti-CD3 heteroconjugate antibody in human renal cell carcinoma xenograft models", Cancer Lett. 86:127-134.
Niederkorn, J.Y. et al., 1993, "Effect of anti-ganglioside antibodies on the metastatic spread of intracular melanomas in a nude mouse model of human uveal melanoma," Curr. Eye Res. 12:347-358.
Weiner, L.M. et al., 1993, "A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erb-2 and CD16," Cancer Res. 53:94-100.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptides and monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides and monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and monoclonal antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1903553

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.